Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;15(3):300-5.
doi: 10.1038/nm.1921. Epub 2009 Feb 22.

Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells

Affiliations

Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells

Markus Moser et al. Nat Med. 2009 Mar.

Abstract

Integrin activation is essential for the function of all blood cells, including platelets and leukocytes. The blood cell-specific FERM domain protein Kindlin-3 is required for the activation of the beta1 and beta3 integrins on platelets. Impaired activation of beta1, beta2 and beta3 integrins on platelets and leukocytes is the hallmark of a rare autosomal recessive leukocyte adhesion deficiency syndrome in humans called LAD-III, characterized by severe bleeding and impaired adhesion of leukocytes to inflamed endothelia. Here we show that Kindlin-3 also binds the beta2 integrin cytoplasmic domain and is essential for neutrophil binding and spreading on beta2 integrin-dependent ligands such as intercellular adhesion molecule-1 and the complement C3 activation product iC3b. Moreover, loss of Kindlin-3 expression abolished firm adhesion and arrest of neutrophils on activated endothelial cells in vitro and in vivo, whereas selectin-mediated rolling was unaffected. Thus, Kindlin-3 is essential to activate the beta1, beta2 and beta3 integrin classes, and loss of Kindlin-3 function is sufficient to cause a LAD-III-like phenotype in mice.

PubMed Disclaimer

Comment in

  • When integrins fail to integrate.
    Hidalgo A, Frenette PS. Hidalgo A, et al. Nat Med. 2009 Mar;15(3):249-50. doi: 10.1038/nm0309-249. Nat Med. 2009. PMID: 19265824 Free PMC article. No abstract available.

References

    1. J Biol Chem. 1998 Dec 11;273(50):33588-94 - PubMed
    1. J Exp Med. 1998 Jul 6;188(1):119-31 - PubMed
    1. J Clin Invest. 1997 Oct 1;100(7):1725-33 - PubMed
    1. Nat Med. 2009 Mar;15(3):313-8 - PubMed
    1. Immunity. 2002 Apr;16(4):547-58 - PubMed

Publication types